Form4insider filings, from the source

Company · CIK 0001557746 · SIC 2834 — Pharmaceutical Preparations · Nasdaq

Aclaris Therapeutics, Inc. · ACRS

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Aug 1, 2026 FMForm 4 →Aug 4, 5:03 pm EDTRoland Wilhelm KolbeckChief Scientific Officer48,760$5.20$64,40223,990—
Jun 5, 2026 MForm 4 →Jun 8, 4:15 pm EDTAnand MehraDirector11,580——726,403—
Jun 5, 2026 MForm 4 →Jun 8, 4:15 pm EDTAndrew N SchiffDirector11,580——25,540—
Jun 5, 2026 MForm 4 →Jun 8, 4:15 pm EDTWilliam D. HumphriesDirector11,580——45,105—
Jun 5, 2026 MForm 4 →Jun 8, 4:15 pm EDTChristopher P. MolineauxDirector11,580——69,536—
Jun 5, 2026 MForm 4 →Jun 8, 4:15 pm EDTVincent MilanoDirector11,580——28,896—
Jun 5, 2026 MForm 4 →Jun 8, 4:15 pm EDTMaxine GowenDirector11,580——33,334—

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Aug 1, 2026 MForm 4 →Aug 4, 5:03 pm EDTRoland Wilhelm KolbeckChief Scientific Officer36,375——109,125—
Jun 4, 2026 AMForm 4 →Jun 8, 4:15 pm EDTAnand MehraDirector64,917——0—
Jun 4, 2026 AMForm 4 →Jun 8, 4:15 pm EDTAndrew N SchiffDirector64,917——0—
Jun 4, 2026 AMForm 4 →Jun 8, 4:15 pm EDTWilliam D. HumphriesDirector64,917——0—
Jun 4, 2026 AMForm 4 →Jun 8, 4:15 pm EDTChristopher P. MolineauxDirector64,917——0—
Jun 4, 2026 AMForm 4 →Jun 8, 4:15 pm EDTVincent MilanoDirector64,917——0—
Jun 4, 2026 AMForm 4 →Jun 8, 4:15 pm EDTMaxine GowenDirector64,917——0—